The MMSE is not an adequate screening cognitive instrument in studies of late-life depression
- 1 January 2009
- journal article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 43 (4) , 464-470
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Predicting 6‐week treatment response to escitalopram pharmacotherapy in late‐life major depressive disorderInternational Journal of Geriatric Psychiatry, 2007
- Prefrontal Neuropsychological Predictors of Treatment Remission in Late-Life DepressionNeuropsychopharmacology, 2004
- An 8-Week Multicenter, Parallel-Group, Double-Blind, Placebo-Controlled Study of Sertraline in Elderly Outpatients With Major DepressionAmerican Journal of Psychiatry, 2003
- Cognitive Behavioral Psychotherapy for Depression Following StrokeStroke, 2003
- The agreement of the Mattis Dementia Rating Scale with the Mini-Mental State ExaminationInternational Journal of Geriatric Psychiatry, 2002
- A Double-Blind, Placebo-Controlled Clinical Trial of Fluoxetine in Geriatric Patients With Major DepressionInternational Psychogeriatrics, 1995
- The reliability and validity of the mini-mental state in a British community surveyJournal of Psychiatric Research, 1989
- The clinical utility of the Dementia Rating Scale for assessing Alzheimer patientsJournal of Chronic Diseases, 1984
- Limits of the ‘Mini-Mental State’ as a screening test for dementia and delirium among hospital patientsPsychological Medicine, 1982
- “Mini-mental state”Journal of Psychiatric Research, 1975